Search
for

    Glossary Semaglutide

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist primarily used for the treatment of type 2 diabetes and obesity. Recent studies have suggested that semaglutide may have potential implications in hair biology, particularly in promoting hair growth and reducing hair loss, possibly due to its effects on metabolic health and inflammation. Its relevance to hair loss lies in its ability to influence factors that can contribute to hair follicle health, making it a subject of interest in the exploration of new treatments for conditions like androgenetic alopecia. Key distinguishing characteristics include its mechanism of action in regulating appetite and glucose metabolism, which may indirectly support hair follicle function.

    Related Terms

    Research 10 of 106

    1. Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs Journal of Clinical Medicine · 2023 · 29 citations
    2. Alopecia and Semaglutide: Connecting the Dots for Patient Safety Journal of Cosmetic Dermatology · 2025 · 4 citations
    3. Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review 2025 · 1 citations
    4. New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching Preprints.org · 2026
    5. Semaglutide and the Skin: An Overview of Current Evidence Quality in Sport · 2026
    6. Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report Cureus · 2026
    7. 53028 Semaglutide and Hair Loss: A Real-World Analysis Journal of the American Academy of Dermatology · 2024
    8. Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights Journal of Pharmaceutical Research · 2026
    9. Semaglutide-associated worsening of atypical anorexia nervosa in an adolescent girl: case report BJPsych Open · 2025
    10. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers in Endocrinology · 2021 · 59 citations
    All research results →

    Community 1

    1. Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here. Reddit · 19 Nov 2023

    Learn

    — no results

    Try a deeper search in learn →